First Page | Document Content | |
---|---|---|
Pharmaceuticals policy Pharmacology Pharmaceutics Therapeutics Prescription Drug User Fee Act Center for Drug Evaluation and Research Drug Master File Generic drug Abbreviated New Drug Application Food and Drug Administration Pharmaceutical industry Pharmaceutical sciences | GDUFA Public Mtg Min[removed]Add to Reading ListSource URL: www.fda.govDownload Document from Source WebsiteFile Size: 45,77 KBShare Document on Facebook |
CENTER FOR DRUG EVALUATION AND RESEARCH DRUG SAFETY PRIORITIES 2017DocID: 1ueGS - View Document | |
CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 208573Orig1s000 SUMMARY REVIEWDocID: 1t19G - View Document | |
CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 022526Orig1s000 SUMMARY REVIEWDocID: 1sZi5 - View Document | |
MEMORANDUM DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCHDocID: 1sPXO - View Document | |
Abstract # 2639 Enhanced (Q)SAR Models for Prediction Rodent Carcinogenicity Naomi L. Kruhlak1, Dongyu Guo1, Kevin P. Cross2, Lidiya Stavitskaya1 FDA Center for Drug Evaluation and Research (CDER), 10903 New Hampshire ADocID: 1swgc - View Document |